Aspirin and warfarin for thromboembolic disease after total joint arthroplasty

Clinical Orthopaedics and Related Research

Volumn 324, Issue , 1996, Pages 251-258

  Lotke, Paul A ^a   Palevsky, Harold ^a   Keenan, Andrew M ^b   Meranze, Steven ^c   Steinberg, Marvin E ^a   Ecker, Malcolm L ^a   Kelley, Mark A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL CENTER OF DELAWARE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; MACROSALB TC 99M; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; FEMORAL VEIN; HUMAN; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHLEBOGRAPHY; PHYSIOTHERAPY; POPLITEAL VEIN; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SURGICAL PATIENT; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

EID: 0030045387     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199603000-00031     Document Type: Article

References (39)

1. Amstutz HC, Friscia DA, Dorey F, Carney BT: Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement. J Bone Joint Surg 71A:321-326, 1989.
2. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 308: 235-246, 1994.
3. Beisaw NE, Comerota AJ, Groth HE, et al: Dihydroertotamine/heparin in the prevention of deepvein thrombosis after total hip replacement. J Bone Joint Surg 70A:2-10, 1988.
4. Bingham JB, Meyer OO, Pohle FJ: Studies on the hemorrhagic agent 3,3′-methylenebis (4-hydroxycoumarin): Its effect on the prothrombin and coagulation time of the blood of dogs and humans. Am J Med Sci 202:563-578, 1941.
5. Carson J, Kelley MA, Duff A, et al: The clinical course of pulmonary embolism. N Engl J Med 326: 1240-1245, 1992.
6. Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 318:1162-1173, 1988.
7. DeLee JC, Rockwood CA: The use of aspirin in thromboembolic disease. J Bone Joint Surg 62A: 149-152, 1980.
8. Evans JA, Dee JF: Anticoagulant treatment of postoperative venous thrombosis and pulmonary embolism. N Engl J Med 238:1-5, 1948.
9. Faunø P, Suomalainey AO, Rehnberg V, et al: Prophylaxis for prevention of venous thromboembolism after total knee arthroplasty: Comparison between unfractionated and low molecular weight heparin. J Bone Joint Surg 76A:1814-1818, 1994.
10. Foley M, Maslack MM, Rothman RH, et al: Pulmonary embolism after hip or knee replacement: Postoperative changes on pulmonary scintigrams in asymptomatic patients. Radiology 172:481-485, 1989.
11. Francis CS, Pellegrini VD, Stulberg BN, et al: Prevention of venous thrombosis after total knee arthroplasty. J Bone Joint Surg 72A:976-982, 1990.
12. Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S: Two-step warfarin therapy. JAMA 249:374-378, 1983.
13. George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324:27-39, 1991.
14. Grady-Benson JC, Oishi CS, Hanson PB, et al: Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty. J Bone Joint Surg 76A:1649-1657, 1994.
15. Haas B, Insall JN, Scuderi GR, Windsor RE, Ghelman B: Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg 72A:27-31, 1990.
16. Haas JB, Tribus CB, Insall JN, et al: The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg 74B:799-802, 1992.
17. Harris WH, Athanasoulis CA, Waltman AC, Salzman EW: High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement. J Bone Joint Surg 64A:63-66, 1982.
18. 2 pulmonary scans. J Bone Joint Surg 66A: 1388-1393, 1984.
19. Hartman JT, Pugh JL, Smith RD, et al: Cyclic sequential compression of the lower limb in prevention of deep venous thrombosis. J Bone Joint Surg 64A:1059-1062, 1982.
20. Hull RD, Raskob GE, Hirsh J, et al: Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 315: 1109-1114, 1986.
21. Hull RD, Raskob GE, Rosenbloom D, et al: Heparin for 5 days with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 322: 1260-1264, 1990.
22. Hull RH, Delmore T, Carter C, et al: Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 306:189-194, 1982.
23. Josefsson G, Dahlqvist A, Bodfors B: Prevention of thromboembolism in total hip replacement. Acta Orthop Scand 58:626-629, 1987.
24. Lieberman JR, Geevts WH: Prevention of thromboembolism after total hip and knee arthroplasty. Current concepts review. J Bone Joint Surg 76A: 1239-1250, 1994.
25. Lotke PA, Ecker ML, Alavi A, Berkowitz H: Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg 66A:202-208, 1984.
26. Lotke PA, Steinberg, ME, Ecker ML: The significance of deep venous thrombosis in the lower extremity after total joint arthroplasty. Clin Orthop 29:925-930, 1994.
27. Lynch AF, Bourne RB, Rorabeck CH, Rankin RN, Donald A: Deep-vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg 70A:11-14, 1988.
28. McKenna R, Galante J, Bachmann F, et al: Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J 280:514-517, 1980.
29. Mohr DN, Silverstein MD, Ilstrup DM, Heit JM, Morrey BF: Venous thromboembolism associated with hip and knee arthroplasty. Current prophylactic practices and outcomes. Mayo Clin Proc 67: 861-870, 1992.
30. Moser KM, LeMoine JR: Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med 94:439-444, 1981.
31. Paiement G, Wessinger SJ, Harris WJ: Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery. Clin Orthop 233: 188-193, 1987.
32. Paiement G, Wessinger SJ, Waltman AC, Harris WH: Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 2:23-26, 1987.
33. Patrono C: Aspirin as an antiplatelet drug. New Engl J Med 330:1287-1294, 1994.
34. PIOPED Investigators: Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis. J Am Med Assoc 263:2753-2759, 1990.
35. Rabinov K, Paulin S: Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 104: 134-144, 1972.
36. RD Heparin Arthroplasty Group: RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg 76A:1174-1185, 1994.
37. Stulberg BN, Insall JN, Williams GW, Ghelman B: Deep-vein thrombosis following total knee replacement. J Bone Joint Surg 66A:194-201, 1984.
38. Sutherland CJ, Schurman JR: Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop 219:158-162, 1987.
39. Woolson ST, Watl MJ: Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. J Bone Joint Surg 507:507-512, 1991.